✦ LIBER ✦

Striatal AMPA Receptor Binding Is Unaltered in the MPTP-Lesioned Macaque Model of Parkinson's Disease and Dyskinesia

✍ Scribed by M.A. Silverdale; A.R. Crossman; J.M. Brotchie

Book ID: 115607681
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 118 KB
Volume: 174
Category: Article
ISSN: 0014-4886
DOI: 10.1006/exnr.2001.7854

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

l-DOPA pharmacokinetics in the MPTP-lesi

l-DOPA pharmacokinetics in the MPTP-lesioned macaque model of Parkinson's disease

✍ Huot, Philippe; Johnston, Tom H.; Koprich, James B.; Fox, Susan H.; Brotchie, Jo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 323 KB

Alterations of striatal NMDA receptor su

Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease

✍ P.J. Hallett; A.W. Dunah; P. Ravenscroft; S. Zhou; E. Bezard; A.R. Crossman; J.M 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 458 KB

Topiramate reduces levodopa-induced dysk

Topiramate reduces levodopa-induced dyskinesia in the MPTP-lesioned marmoset model of Parkinson's disease

✍ Monty A. Silverdale; S.L. Nicholson; A.R. Crossman; J.M. Brotchie 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views

## Abstract Overactive AMPA receptor‐mediated transmission may be involved in the pathogenesis of levodopa‐induced dyskinesia. The mechanism of action of the anticonvulsant drug topiramate involves attenuation of AMPA receptor‐mediated transmission. In this study, the potential antidyskinetic actio

Striatal delta opioid receptor binding i

Striatal delta opioid receptor binding in experimental models of Parkinson's disease and dyskinesia

✍ Penelope J. Hallett; J.M. Brotchie 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB

Enhanced delta opioid receptor transmission may represent an endogenous compensatory mechanism in parkinsonism to reduce the activity of the indirect striatopallidal pathway following dopamine depletion. Furthermore, increased delta opioid receptor transmission may be causative in the production of

μ- and δ-Opioid Receptor Antagonists Red

μ- and δ-Opioid Receptor Antagonists Reduce Levodopa-Induced Dyskinesia in the MPTP-Lesioned Primate Model of Parkinson's Disease

✍ Brian Henry; Susan H. Fox; Alan R. Crossman; Jonathan M. Brotchie 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 75 KB

The selective mu-opioid receptor antagon

The selective mu-opioid receptor antagonist adl5510 reduces levodopa-induced dyskinesia without affecting antiparkinsonian action in mptp-lesioned macaque model of Parkinson's disease

✍ James B. Koprich; Susan H. Fox; Tom H. Johnston; Allan Goodman; Bertrand Le Bour 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB

## Abstract In Parkinson's disease (PD), dyskinesia develops following long‐term treatment with 3,4‐dihydroxyphenylalanine (L‐dopa). Given the prominent role of the opioid system in basal ganglia function, nonselective opioid receptor antagonists have been tested for antidyskinetic efficacy in the